$243 Thousand is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 45 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BR | Exit | BROADRIDGE FINANCIAL SOLUTIONS | $0 | – | -14 | -100.0% | -0.00% | – |
| VBK | Exit | VANGUARD SMALL-CAP GROWTH ETF | $0 | – | -48 | -100.0% | -0.00% | – |
| TFFP | Exit | TFF PHARMACEUTICALS INC | $0 | – | -22,066 | -100.0% | -0.00% | – |
| GOOGL | Exit | ALPHABET INC | $0 | – | -76 | -100.0% | -0.00% | – |
| VOT | Exit | VANGUARD MID-CAP GROWTH INDEX FUNDetfs | $0 | – | -52 | -100.0% | -0.00% | – |
| MGK | Exit | VANGUARD MEGA CAP GROWTH INDEX FUNDetfs | $0 | – | -44 | -100.0% | -0.00% | – |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -33 | -100.0% | -0.00% | – |
| VOO | Exit | VANGUARD 500 INDEX FUNDetfs | $0 | – | -25 | -100.0% | -0.00% | – |
| ADSK | Exit | AUTODESK INC | $0 | – | -51 | -100.0% | -0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-02-28
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 44 | Q2 2024 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 41 | Q2 2024 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 36 | Q2 2024 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AILERON THERAPEUTICS INC | March 05, 2024 | 1,812,627 | 6.2% |
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-09-17 |
| N-PX | 2024-09-03 |
| 13F-HR/A | 2024-08-29 |
| 13F-HR/A | 2024-08-29 |
| 13F-HR/A | 2024-08-29 |
| 13F-HR/A | 2024-08-29 |
| 13F-HR/A | 2024-08-29 |
| 13F-HR | 2024-08-01 |
| 4 | 2024-06-17 |
| 4 | 2024-06-12 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.